Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: Preliminary corroboration of the intergroup experience

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 4, 2000, Pages 861-866

  Cooper, Jay S ^a   Lee, Heather ^a   Torrey, Meg ^a   Hochster, Howard ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Nasopharynx; Outcome; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FOLLOW UP; HUMAN; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 0034237499     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00558-7     Document Type: Article

References (10)

1. Al-Sarraf M., LeBlanc M., Giri S., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer Phase III randomized intergroup study 0099 . J Clin Oncol. 16:1998;1310-1317.
2. Bears O.H., Henson D.E., Hutter R.V.P., et al. American Joint Committee on Cancer Manual for staging of cancer . 4th ed. 1992;J. B. Lippincott, Philadelphia, PA.
3. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
4. Tan E.H., Chua E.T., Wee J., et al. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma Toxicities and preliminary results . Int J Radiat Oncol Biol Phys. 45:1999;597-601.
5. Cheng S.H., Jian J.J., Tsai S.Y., et al. Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 41:1998;755-762.
6. Geara F.B., Glisson B.S., Sanguineti G., et al. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal cancer. Cancer. 79:1997;1279-1286.
7. VUMCA I Trial. Preliminary results of randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥ N2, M0) undifferentiated nasopharyngeal carcinoma A positive effect on progression-free survival . Int J Radiat Oncol Biol Phys. 35:1996;463-469.
8. Chan A.T.C., Teo P.L.M., Leung T.W.T., et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 33:1995;569-577.
9. Ho J.H.C. Stage classification of nasopharyngeal carcinoma A review . De The G., Eto Y. Nasopharyngeal carcinoma Etiology and control (IARC Scientific Publications No. 20) . 1978;99-113 International Agency for Research on Cancer, Lyon.
10. Chua D.T.T., Sham J.S.T., Choy D., et al. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with local-regionally advanced nasopharyngeal carcinoma. Cancer. 83:1998;2270-2283.